Get started
Author

Raja Mehdi

Observed names: R MEHDI, R Mehdi, R. Mehdi
ORCID: 0009-0004-7899-3011
Observed ORCID: 0009-0004-7899-3011
OpenAlex ID: A5085157986
Sequential expression of bone morphogenetic protein, tumor necrosis factor, and their receptors in bone-forming reaction after mouse femoral marrow ablation
1998 · T SHIMIZU, R MEHDI, et al. · Bone · 44
Characterization of Plasma Cell-Free DNA Variants as of Tumor or Clonal Hematopoiesis Origin in 16,812 Advanced Cancer Patients
2025 · Daniel Magee, Valeriy Domenyuk, et al. · Clinical Cancer Research · 40
PDF
Expression of Bone Morphogenetic Protein and its Receptors in Osteosarcoma and Malignant Fibrous Histiocytoma
2000 · R. Mehdi · Japanese Journal of Clinical Oncology · 17
Advantages of concurrent use of anabolic and antiresorptive agents over single use of these agents in increasing trabecular bone volume, connectivity, and biomechanical competence of rat vertebrae
1999 · S Kobayashi, T Shimizu, et al. · Bone · 11
Synchronous Percutaneous Biopsy and Cryoablation for Suspicious Solitary Pulmonary Nodules
2026 · Sameer Rehman, Shreyas Naidu, et al. · Journal of Vascular and Interventional Radiology
Data from Characterization of Plasma Cell-Free DNA Variants as of Tumor or Clonal Hematopoiesis Origin in 16,812 Advanced Cancer Patients
2025 · Daniel Magee, Valeriy Domenyuk, et al.
Supplemental Material 1 from Characterization of Plasma Cell-Free DNA Variants as of Tumor or Clonal Hematopoiesis Origin in 16,812 Advanced Cancer Patients
2025 · Daniel Magee, Valeriy Domenyuk, et al.
Supplemental Table 2 from Characterization of Plasma Cell-Free DNA Variants as of Tumor or Clonal Hematopoiesis Origin in 16,812 Advanced Cancer Patients
2025 · Daniel Magee, Valeriy Domenyuk, et al.
Works count: 8
Citation count: 112
H-index: 4
I10-index: 4
Year
Topic
Type